بدائل البحث:
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
linked decrease » marked decrease (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
linked decrease » marked decrease (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
-
1841
-
1842
Incidence number, ASIR under the age of 20 in 204 countries and territories in 2021.
منشور في 2025الموضوعات: -
1843
-
1844
DALYs number, ASDR under the age of 20 in 204 countries and territories in 2021.
منشور في 2025الموضوعات: -
1845
-
1846
-
1847
-
1848
-
1849
-
1850
-
1851
-
1852
-
1853
-
1854
Trends analysis in diabetes mellitus diagnosis according to relative handgrip strength.
منشور في 2024الموضوعات: -
1855
-
1856
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
1857
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
1858
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
1859
-
1860